New England Deaconess Hospital Corporation
53Patents
0Active
53Granted
38Portfolio score
Filing activity: Nov 25, 1981 → Aug 2, 1996
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5211658A | Method and device for performing endovascular repair of aneurysms | Human Necessities | 489 | Expired |
| US5082005A | Surgical access device | Human Necessities | 244 | Expired |
| US4503568A | Small diameter vascular bypass and method | Human Necessities | 223 | Expired |
| US5759542A | Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases | Chemistry; Metallurgy | 215 | Expired |
| US5114401A | Method for central venous catheterization | Human Necessities | 150 | Expired |
| US5614184A | Recombinant human erythropoietin mutants and therapeutic methods employing them | Human Necessities | 138 | Expired |
| US5019393A | Biocompatible substance with thromboresistance | Human Necessities | 89 | Expired |
| US5167960A | Hirudin-coated biocompatible substance | Human Necessities | 81 | Expired |
| US5580853A | Modified polypeptides with increased biological activity | Human Necessities | 60 | Expired |
| US4703039A | Method of producing biologically active molecules having extended life time | Human Necessities | 51 | Expired |
| US4871768A | Dietary supplement utilizing .omega.-3/medium chain trigylceride mixtures | Human Necessities | 50 | Expired |
| US4752618A | Method of minimizing efects of infection through diet | Human Necessities | 48 | Expired |
| US4877599A | Detection of vascular disease with labelled antibodies | Human Necessities | 48 | Expired |
| US5683698A | Formulation for alleviating symptoms associated with arthritis | Emerging Cross-Sectional Technologies | 45 | Expired |
| US4914021A | Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses | Emerging Cross-Sectional Technologies | 43 | Expired |
| US5972890A | Synthetic peptides for arterial imaging | Human Necessities | 42 | Expired |
| US5320846A | Method and composition for testing patients with metabolic depleting diseases | Human Necessities | 42 | Expired |
| US4921789A | Marker for colorectal carcinoma and methods of detecting the same | Emerging Cross-Sectional Technologies | 39 | Expired |
| US4661471A | Method of inhibiting and inducing human platelet aggregation | Human Necessities | 31 | Expired |
| US4820731A | Parenteral dietary supplement and method of minimizing effects of infection through diet | Human Necessities | 30 | Expired |
| US5397778A | Enteral formulations for treatment of inflammation and infection | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5386832A | Liver function breath test using aromatic amino acids | Human Necessities | 24 | Expired |
| US5112615A | Soluble hirudin conjugates | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5661180A | Structured lipid containing gama-linolenic or dihogamma-linolenic fatty acid residue, a medium chain (C.sub.6 -C.sub.12) fatty acid residue, and a n-3 fatty acid residue | Human Necessities | 21 | Expired |
| US5200400A | Method for inhibiting allograft rejection using photoactivatable nucleotides or nucleosides | Human Necessities | 21 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.